ArticleEuroasian journal of hepato-gastroenterology
Bridging the Treatment Access Gap: Janus Kinase Inhibitors as First-line Advanced Therapy for Inflammatory Bowel Disease in Resource-variable Settings.
Rowan Bandaranaike et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.